Loading clinical trials...
Loading clinical trials...
Even though rare disorders usually have limited case numbers, they have induced huge impacts on patients and their families, and has heavily burdened on our society and healthcare system as well. Therefore, it is essential to detect the occurrence of disorders and thus take appropriate measures as early as possible. The preventive goal is based on comprehensive understanding on rare disorders, available diagnostic and therapeutic approaches. However, studies related to rare disorders are often impeded by limited sample sizes and infrequent exchange of research materials among institutes. After referring to foreign experiences, the investigators have noticed that a non-profit tissue bank which can reposit biological samples and thus provide researchers access to samples, may be a solution. Through sharing this public asset, the investigators believe not only quantity and quality of rare disorder studies will be improved, the collaboration between various research institutes can also be strengthened afterwards. Most important of all, those achievements can ultimately benefit patients, families and the whole society.
Investigation Plan 1. Study Period:From 2009 to 2013 2. Study Population:Patients with rare disorders. 3. Planned Number of Subjects: 300\~500 Subjects will be included in CMU. 4. Inclusive Criteria:A patient who is clinically diagnosed as one of rare disorders notified by Department of Health or our organization. Or a patient who is diagnosed as a probable rare disorder case by physicians. 5. Exclusive Criteria:Patients whose physical or mental status is not suitable by the judgment of health professionals. Or a patient who is \<20 years old or interdictory, yet without getting the permission from his/her legal representatives. 6. Study Site: Mainly in OPD that related to rare disorders. 7. Study Materials:Blood (for plasma, DNA and cell line), a questionnaire and a chart review form. Tissue samples are acceptable as well. 8. Application of collected materials:Samples and information will be restored in appropriate manner, and researchers will be encouraged to apply them for biological studies in the field of rare disorders thereafter.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Start Date
December 1, 2009
Last Updated
June 29, 2011
500
ESTIMATED participants
Lead Sponsor
China Medical University Hospital
NCT06729554
NCT07130071
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions